A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

The Alzheimer’s Society is on a mission to tell the “hundreds of thousands” of real stories of living with dementia after ...

Social isolation is a top dementia risk factor and can exacerbate existing dementia symptoms and caregiver stress, Alzheimer ...

Brains affected by Alzheimer's disease are characterized by damaging clumps and tangles that interfere with neurons – but a ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Alzheimer’s breakthrough after drug treatment success - The study found that the medication, called RI-AG03, was effective at ...

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...

A daughter chooses to care for her mother with Alzheimer's, defying societal expectations and finding growth and connection ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

Alzheimer’s Society CEO, Kate Lee, said: “What an achievement for our partnership with the FA! The power of the partnership ...

BPGbio to present novel Huntington's Disease and Alzheimer's Disease research at the Society for Neuroscience 2024 annual meeting.